Asialoerythropoietin Is a Strong Modulator of Angiogenesis by Bone-Marrow Cells

REFERENCES

• Sylvester K G, Longaker M T. Stem cells. Arch Surg. 2004; 139: 93–99
   PubMedGoogle Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara H, Ikeda H, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic angiogenesis using cell transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: A randomized controlled trial. Lancet 2002; 360: 427–435
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Biology of erythropoietin. Clin Invest 1994; 72: S3–S10, (Suppl 6)
   PubMedGoogle Scholar
• Anagnostou A, Liu Z, Steiner M, Chin K, Lee E S, Kessimian N, Noguchi C T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91: 3974–3978
   PubMed Web of Science ®Google Scholar
• Parsa C J, Kim J, Riel R U, Pascal L S, Thompson R B, Petrofski J A, Matsumoto A, Stamler J S, Koch W J. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts. J Biol Chem 2004; 279: 20655–20662
   PubMed Web of Science ®Google Scholar
• Nagai A, Nakagawa E, Choi H B, Hatori K, Kobayashi S, Kim S U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 2001; 60: 386–392
   PubMed Web of Science ®Google Scholar
• Westenfelder C, Biddle D L, Baranowski R L. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808–820
   PubMed Web of Science ®Google Scholar
• Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoshi M, Tsukamoto O, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Shiraga M, Kitakaze M, Hori M. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006; 48: 176–84
   Google Scholar
• Minamino T, Kitakaze M. New therapeutic application of erythropoietin against ischemic heart diseases. J Pharmacol Sci 2006; 101: 179–181
   PubMed Web of Science ®Google Scholar
• Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck H H, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel T C, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren A L. Erythropoietin therapy for acute stroke is safe and beneficial. Mol Med 2002; 8: 495–505
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu C, Wang X, Gerwien J G, Schrattenholz A, Sandberg M, Leist M, Blomgren K. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia–ischemia as potently as erythropoietin. J Neurochem 2004; 91: 900–910
   PubMed Web of Science ®Google Scholar
• Erbayraktar S, Grasso G, Sfacteria A, Xie Q W, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist M A, Pedersen L O, Cerami-Hand C, Wuerth J P, Cerami A, Brines M. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 2003; 100: 6741–6746
   PubMed Web of Science ®Google Scholar
• Miranville A, Heeschen C, Sengenès C, Curat C A, Busse R. Bouloumiè Improvement A. of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004; 110: 349–355
   PubMed Web of Science ®Google Scholar
• Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher A M, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003; 102: 1340–1346
   PubMed Web of Science ®Google Scholar
• Risau W. Mechanism of angiogenesis. Nature 1997; 386: 671–674
   PubMed Web of Science ®Google Scholar
• Anagnostou U, Lee E S, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87: 5978–5982
   PubMed Web of Science ®Google Scholar
• Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93: 2627–2636
   PubMed Web of Science ®Google Scholar
• Li F, Chong Z Z, Maiese K. Erythropoietin on a tightrope: Balancing neuronal and vascular protection between intrinsic and extrinsic pathway. Neurosignals 2004; 13: 265–289
   PubMed Web of Science ®Google Scholar
• Joyeux-Faure M, Godin-Ribuot D, Ribuot C. Erythropoietin and myocardial protection: What's new?. Fundam Clin Pharmacol 2005; 19: 439–446
   Google Scholar
• Rafiee P, Shi Y, Su J, Pritchard K A, Jr., Tweddell J S, Baker J E. Erythropoietin protects the infant heart against ischemi–reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol. 2005; 100: 187–197
   PubMed Web of Science ®Google Scholar
• Alvarez Arroyo M V, Castilla M A, Gonzalez Pacheco F R, Tan D, Riesco A, Casado S, Caramelo C. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol. 1998; 9: 1998–2004
   PubMed Web of Science ®Google Scholar
• Galeano M, Altavilla D, Cucinotta D, Russo G, Calò M, Bitto A, Marini H, Marini R, Adamo E B, Seminara P, Minutoli L, Torre V, Squadrito F. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004; 53: 2509–2517
   PubMed Web of Science ®Google Scholar
• Higuchi M, Oh-eda M, Kuboniwa H, Tomonoh K, Shimonaka Y, Ochi N. Role of sugar chain in the expression of the biological activity of human erythropoietin. J Biol Chem 1992; 267: 7703–7709
   PubMed Web of Science ®Google Scholar